Literature DB >> 23678845

Why some previous drug abuse preventive programs had low effectiveness?

Rahele Samouei1, Ayatollah Sohrabi, Mohammad Hosein Yarmohammadian.   

Abstract

INTRODUCTION: Considering the significant increase of drug abuse in national and international scopes, and the priority of the preventive programs (due to savings in cost and energy), this study aims to investigate the efficiency of drug abuse preventive programs.
METHODS: This is an analytical-descriptive study, conducted in Iran on a sample of 600 individuals composed of academicians, experts, specialists, and officials. Verbal, individual interviews were performed based on a semi-structured interview-guide, and the resulted data was coded, categorized, and reported.
RESULTS: The causes of lower effectiveness of previous preventive programs were as following: a) the features of preventive programs (37.7%): unsustainability, not matching the target group's characteristics, Lack of targeted programs, etc., b) sociocultural issues (19.79%): families, and society's unawareness, adverse social factors, etc.
CONCLUSION: The drug abuse preventive programs are of significant importance. However, their efficiency and effectiveness are subjected to special requirements and considerations that if not met, results will not be achieved.

Entities:  

Mesh:

Year:  2013        PMID: 23678845     DOI: 10.5455/medarh.2013.67.68-72

Source DB:  PubMed          Journal:  Med Arch        ISSN: 0350-199X


  2 in total

1.  Comparison of Buprenorphine and Buprenorphine/naloxone in Detoxification of Opioid-dependent Men.

Authors:  Hassan Ziaaddini; Shima Heshmati; Maryam Chegeni; Mahboobeh Mousavi-Ramezanzade; Shahrzad Mazhari
Journal:  Addict Health       Date:  2018-10

2.  Prevalence of Substance Abuse Among Dormitory Students of Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Authors:  Akbar Babaei Heydarabadi; Ali Ramezankhani; Hasan Barekati; Marjan Vejdani; Keyvan Shariatinejad; Rahman Panahi; Seyed Hanan Kashfi; Masoumeh Imanzad
Journal:  Int J High Risk Behav Addict       Date:  2015-06-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.